Efficient One-Pot Synthesis
of 2-Substituted Benzimidazoles from Triacyloxyborane
Intermediates

Wenge Cui; Robert B. Kargbo; Zohreh Sajjadi-Hashemi; Feryan Ahmed; Jolicia F. Gauuan

doi:10.1055/s-0031-1290129

LETTER

Efficient One-Pot Synthesis of 2-Substituted Benzimidazoles from Triacyloxyborane Intermediates

Wenge Cui*, Robert B. Kargbo, Zohreh Sajjadi-Hashemi, Feryan Ahmed, Jolicia F. Gauuan
Department of Medicinal Chemistry, AMRI, 26 Corporate Circle, Albany, NY 12212-5098, USA
Fax: +1(518)5122079; e-Mail: wenge.cui@amriglobal.com;

Abstract

All articles of this category

Abstract

An efficient one-pot synthesis of 2-substituted benzimidazoles via triacyloxyborane intermediates is reported. The mild protocol is efficient and tolerant of acid-labile functional groups.

Key words

benzimidazoles - borane-THF - carboxylic acids - triacyloxyboranes - diacyloxyboric acids - benzoxazoles

Full Text

References

References and Notes

<A NAME="RS54111ST-1A">1a</A> Fellenius E. Berglindh T. Sachs G. Olbe L. Elander B. Sjostrand SE. Wallmark B. Nature (London) 1981, 290: 159

<A NAME="RS54111ST-1B">1b</A> Yamada M. Yura T. Morimoto M. Harada T. Yamada K. Honma Y. Kinoshita M. Sugiura M.
J. Med. Chem. 1996, 39: 596

<A NAME="RS54111ST-2A">2a</A> Eriksson BI. Smith H. Yasothan U. Kirkpatrick P. Nat. Rev. Drug Discovery 2008, 7: 557

<A NAME="RS54111ST-2B">2b</A> Hauel NH. Nar H. Priepke H. Ries U. Stassen J. Wienen W.
J. Med. Chem. 2002, 45: 1757

<A NAME="RS54111ST-2C">2c</A> Ueno H. Katoh S. Yokota K. Hoshi J.-i. Hayashi M. Uchida I. Aisaka K. Hase Y. Cho H. Bioorg. Med. Chem. Lett. 2004, 14: 4281

<A NAME="RS54111ST-3">3</A> Mizuno CS. Chittiboyina AG. Shah FH. Patny A. Kurtz TW. Pershadsingh HA. Speth RC. Karamyan VT. Carvalho PB. Avery MA. J. Med. Chem. 2010, 53: 1076

<A NAME="RS54111ST-4A">4a</A> Spasov AA. Yozhitsa IN. Bugaeva LI. Anisimova VA. Pharm. Chem. J. 1999, 33: 232

<A NAME="RS54111ST-4B">4b</A> Beaulieu PL. Bousquet Y. Gauthier J. Gillard J. Marquis M. McKercher G. Pellerin C. Valois S. Kukolj G. J. Med. Chem. 2004, 47: 6884

<A NAME="RS54111ST-4C">4c</A> Roth T. Morningstar ML. Boyer PL. Hughes SH. Buckheit RW. Michejda CJ. J. Med. Chem. 1997, 40: 4199

<A NAME="RS54111ST-5A">5a</A> Mann J. Baron A. Opoku-Boahen Y. Johansson E. Parkinson G. Kelland LR. Neidle S. J. Med. Chem. 2001, 44: 138

<A NAME="RS54111ST-5B">5b</A> Soderlind K.-J. Gorodetsky B. Singh AK. Bachur NR. Miller GG. Lown JW. Anti-Cancer Drug Des. 1999, 14: 19

<A NAME="RS54111ST-5C">5c</A> Kim JS. Gatto B. Yu C. Liu A. Liu LF. LaVoie EJ. J. Med. Chem. 1996, 39: 992

<A NAME="RS54111ST-5D">5d</A> Chen AY. Yu C. Gatto B. Liu LF. Proc. Natl. Acad. Sci. U.S.A. 1993, 90: 8131

<A NAME="RS54111ST-6">6</A> Janssens F. Torremans J. Janssen M. Stokbroekx RA. Luyckx M. Janssen PAJ. J. Med. Chem. 1985, 28: 1925

<A NAME="RS54111ST-7">7</A> Schwartz G. Fehse K. Pfeiffer M. Walzer K. Leo K. Appl. Phys. Lett. 2006, 89: 83509

<A NAME="RS54111ST-8A">8a</A> Asensio JA. Gomez-Romero P. Fuel Cells 2005, 5

<A NAME="RS54111ST-8B">8b</A> Weber J. Antonietti M. Thomas A. Macromolecules 2007, 40: 1299

For comprehensive reviews on the chemistry of benz-imidazoles, see:

<A NAME="RS54111ST-9A">9a</A> Wright JB. Chem. Rev. 1951, 48: 397

<A NAME="RS54111ST-9B">9b</A> Preston PN. Chem. Rev. 1974, 74: 279

<A NAME="RS54111ST-9C">9c</A> Grimmett MR. Imidazoles and their Benzo Derivatives, In Comprehensive Heterocyclic Chemistry Vol. 5: Katritzky AR. Rees CW. Pergamon Press; Oxford: 1984. p.457-487

<A NAME="RS54111ST-9D">9d</A> Preston PN. Benzimidazoles and Congeneric Tricyclic Compounds, In The Chemistry of Heterocyclic Compounds Part 1, Vol. 40: Weissberger A. Taylor EC. Wiley; New York: 1981. p.6-60

<A NAME="RS54111ST-10A">10a</A> Sluiter J. Christoffers J. Synlett 2009, 63

<A NAME="RS54111ST-10B">10b</A> Czarny A. Wilson WD. Boykin DW. J. Heterocycl. Chem. 1996, 33: 1393

<A NAME="RS54111ST-10C">10c</A> Tidwell RR. Geratz JD. Dann O. Volz G. Zeh D. Loewe H. J. Med. Chem. 1978, 21: 613

<A NAME="RS54111ST-10D">10d</A> Fairley TA. Tidwell RR. Donkor I. Naiman NA. Ohemeng KA. Lombardy RJ. Bentley JA. Cory M. J. Med. Chem. 1993, 36: 1746

<A NAME="RS54111ST-10E">10e</A> Treu M. Karner T. Kousek R. Berger H. Mayer M. McConnell DB. Stadler A. J. Comb. Chem. 2008, 10: 863

<A NAME="RS54111ST-11A">11a</A> Murai K. Takaichi N. Takahara Y. Fukushima S. Fujioka H. Synthesis 2010, 520

<A NAME="RS54111ST-11B">11b</A> Beaulieu PL. Haché B. von Moos E. Synthesis 2003, 1683 ; and references cited therein

<A NAME="RS54111ST-11C">11c</A> Eynde JJV. Delfosse F. Lor P. Van Haverbeke Y. Tetrahedron 1995, 51: 5813

<A NAME="RS54111ST-11D">11d</A> Du L. Wang Y. Synthesis 2007, 675

<A NAME="RS54111ST-12">12</A> Yamamoto Y. Mizuno H. Tsuritani T. Mase T. J. Org. Chem. 2009, 74: 1394

<A NAME="RS54111ST-13A">13a</A> Evindar G. Batey RA. Org. Lett. 2003, 5: 133

<A NAME="RS54111ST-13B">13b</A> Yang D. Fu H. Hu L. Jiang Y. Zhao Y. J. Org. Chem. 2008, 73: 7841

<A NAME="RS54111ST-13C">13c</A> Zou B. Yuan Q. Ma D. Angew. Chem. Int. Ed. 2007, 46: 2598

<A NAME="RS54111ST-13D">13d</A> Murru S. Patel BK. Le Bras J. Muzart J. J. Org. Chem. 2009, 74: 2217

<A NAME="RS54111ST-13E">13e</A> Brian CT. Steer JT. J. Org. Chem. 2003, 68: 6814

<A NAME="RS54111ST-13F">13f</A> She J. Jiang Z. Wang Y. Synlett 2009, 2023

<A NAME="RS54111ST-13G">13g</A> Zheng N. Anderson KW. Huang X. Nguyen HN. Buchwald SL. Angew. Chem. Int. Ed. 2007, 46: 7509

<A NAME="RS54111ST-13H">13h</A> Brasche G. Buchwald SL. Angew. Chem. Int. Ed. 2008, 47: 1932

<A NAME="RS54111ST-13I">13i</A> Brian CT. Brunton SA. Tetrahedron Lett. 2002, 43: 1893

<A NAME="RS54111ST-14A">14a</A> Pelter A. Levitt TE. Nelson P. Tetrahedron 1970, 26: 1545

<A NAME="RS54111ST-14B">14b</A> Collum DB. Chen S. Ganem B. J. Org. Chem. 1978, 43: 4393

<A NAME="RS54111ST-14C">14c</A> Ishihara K. Ohara S. Yamamoto H.
J. Org. Chem. 1996, 61: 4196

<A NAME="RS54111ST-14D">14d</A> Huang Z. Reilly JE. Buckle RN. Synlett 2007, 1026

<A NAME="RS54111ST-15A">15a</A> Ramsden CA. Rose HL. J. Chem. Soc., Perkin Trans. 1 1997, 2319

<A NAME="RS54111ST-15B">15b</A> Nasal A. Kaliszan R. Kuzmierkiewicz W. QSAR 1987, 6: 22

<A NAME="RS54111ST-15C">15c</A> Blacker AJ. Farah MM. Hall MI. Marsden MP. Saidi O. Williams JM. Org. Lett. 2009, 11: 2039

<A NAME="RS54111ST-15D">15d</A> Moorthy JA. Neogi I. Tetrahedron Lett. 2011, 52: 3868

<A NAME="RS54111ST-15E">15e</A> Trivedi R. De S K. Gibbs RA. J. Mol. Catal. A: Chem. 2006, 245: 8

<A NAME="RS54111ST-16A">16a</A> Roeder CJ. Day AR. J. Org. Chem. 1941, 6: 25

<A NAME="RS54111ST-16B">16b</A> Morgan KJ. Turner AM. Tetrahedron 1969, 25: 915

<A NAME="RS54111ST-16C">16c</A> Maras N. Kocevar M. Helv. Chim. Acta 2011, 94: 1860

General Procedure for the Formation of Benzimidazoles
To a carboxylic acid (2 mmol) in toluene (10 mL) in an ice-water bath was added dropwise a solution of borane-THF (1 M, 0.70 mmol) in THF. The mixture was stirred at r.t. for 30 min. Benzene-1,2-diamine (0.66 mmol) was added, and the mixture was heated at reflux with stirring for 12 h. After cooling, the mixture was concentrated in vacuo, and the residue was purified by flash chromatography. The physical data of the products in Table [¹] , entries 1-11, 15, and 16 are consistent with those of reported literatures,^{¹0e,¹¹c,d,¹5} or those of authentic samples. The new compound characterizations are provided below.
tert -Butyl 2-(5-Methyl-1 H -benzo[ d ]imidazol-2-yl)-ethylcarbamate (Table 1, Entry 12)
^¹H NMR (300 MHz, CDCl₃): δ = 7.43 (d, J = 8.1 Hz, 1 H), 7.32 (s, 1 H), 7.04 (d, J = 8.1 Hz, 1 H), 5.40 (br, 1 H), 3.68-3.61 (m, 2 H), 3.12-3.18 (m, 2 H), 2.45 (s, 3 H), 1.40 (s, 9 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 156.7, 152.2, 132.0, 123.7, 114.3, 114.0, 79.9, 38.4, 30.2, 28.4, 21.6. ESI-HRMS: m/z calcd for C₁₅H₂₁N₃O₂ + H⁺: 276.1712; found 2761723. tert -Butyl 4-[(5-Chloro-1 H -benzo[ d ]imidazol-2-yl)-methyl]piperidine-1-carboxylate (Table 1, Entry 13) ^¹H NMR (500 MHz, CD₃OD): δ = 7.53 (d, J = 1.9 Hz, 1 H), 7.47 (d, J = 8.7 Hz, 1 H), 7.20 (dd, J = 1.5, 8.6 Hz, 1 H), 4.15 (d, J = 13.2 Hz, 2 H), 2.83 (d, J = 7.3 Hz, 2 H), 2.76 (br, 2 H), 2.10-2.02 (m, 1 H), 1.66 (d, J = 12.2 Hz, 2 H), 1.44 (s, 9 H), 1.36-1.28 (m, 2 H). ^¹³C NMR (125 MHz, CD₃OD): δ = 156.6, 156.5, 140.4, 137.8, 129.0, 123.8, 116.3, 115.4, 81.0, 44.6, 37.0, 36.4, 33.0, 28.7. ESI-HRMS: m/z calcd for C₁₈H₂₄ClN₃O₂ + H⁺: 350.1635; found: 350.1642.
5-Bromo-2-(thiophen-2-ylmethyl)-1 H -benzo[ d ]-imidazole (Table 1, Entry 14)
^¹H NMR (500 MHz, CD₃OD): δ = 7.72 (d, J = 1.5 Hz, 1 H), 7.47 (d, J = 8.5 Hz, 1 H), 7.41 (dd, J = 1.5, 8.5 Hz, 1 H), 7.32 (dd, J = 1.5, 5.5 Hz, 1 H), 7.04-7.03 (m, 1 H), 6.99 (dd, J = 3.5, 5.0 Hz, 1 H), 4.52 (s, 2 H). ^¹³C NMR (125 MHz, CD₃OD): δ = 155.8, 141.1, 139.4, 138.4, 128.1, 127.6, 126.6, 126.1, 118.7, 117.0, 116.3, 30.3. ESI-HRMS: m/z calcd for C₁₂H₉BrN₂S + H⁺: 292.9748; found: 292.9768.